BillionToOne
Karel joined BillionToOne in March of 2022. He brings 20+ years of experience in all facets of supply chain and materials management spanning inventory management, purchasing, ERP systems, cold chain, production planning, warehousing operations, and vendor & CMO management. His past biotech work experiences include Pendulum Therapeutics, CareDx, Adaptive Biotechnologies, Genomic Health, and Applied Biosystems.
Karel Started his career with Monsanto upon graduation from the University of South Carolina with a BS in Business Administration – Finance.
This person is not in any offices
BillionToOne
4 followers
BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible for all. Our patent-pending molecular counter platform is the only technology platform that can accurately count the DNA molecules to the single-count level.